T-cell and Soluble Co-inhibitory Receptor Expression in Patients With Visceral Leishmaniasis Are Markers of Treatment Response and Clinical Outcome.

MLA

Ademe, Muluneh, et al. “T-Cell and Soluble Co-Inhibitory Receptor Expression in Patients With Visceral Leishmaniasis Are Markers of Treatment Response and Clinical Outcome.” Open Forum Infectious Diseases, vol. 11, no. 11, Oct. 2024, p. ofae649. EBSCOhost, https://doi.org/10.1093/ofid/ofae649.

APA

Ademe, M., Osorio, Y., Fikre, H., Adane, D., Mulaw, T., Travi, B. L., Howe, R., Hailu, A., Abebe, T., & Melby, P. C. (2024). T-cell and Soluble Co-inhibitory Receptor Expression in Patients With Visceral Leishmaniasis Are Markers of Treatment Response and Clinical Outcome. Open Forum Infectious Diseases, 11(11), ofae649. https://doi.org/10.1093/ofid/ofae649

Chicago

Ademe, Muluneh, Yaneth Osorio, Helina Fikre, Desalegn Adane, Tadele Mulaw, Bruno L Travi, Rawliegh Howe, Asrat Hailu, Tamrat Abebe, and Peter C Melby. 2024. “T-Cell and Soluble Co-Inhibitory Receptor Expression in Patients With Visceral Leishmaniasis Are Markers of Treatment Response and Clinical Outcome.” Open Forum Infectious Diseases 11 (11): ofae649. doi:10.1093/ofid/ofae649.